The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Meta-analysis of insulin glargine and cancer risk.
P. Boyle
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
A. Koechlin
No relevant relationships to disclose
P. Boffetta
No relevant relationships to disclose
M. Boniol
No relevant relationships to disclose
G. Bolli
No relevant relationships to disclose
J. Rosenstock
Consultant or Advisory Role - Sanofi